MSpace will be unavailable on Sunday Jan 29, 2023 between the times of 8:00AM CST and 12:00PM CST. Please plan your submissions accordingly.

Show simple item record

dc.contributor.supervisorElias, Brenda (Community Health Sciences) Turner, Donna (Community Health Sciences)en_US
dc.contributor.authorSkrabek, Pamela
dc.date.accessioned2017-01-05T18:55:33Z
dc.date.available2017-01-05T18:55:33Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/1993/31987
dc.description.abstractThe province of Manitoba has set a goal of reducing time from suspicion of cancer to treatment to a target of sixty days. To attain this goal, a baseline understanding of current time intervals is required. This study examined system, diagnostic and treatment delay in adult patients (> 17) diagnosed with Lymphomas from 2005 to 2010 using administrative data (Manitoba Cancer Registry, Manitoba Health billing data and Hospital Abstract data) and a chart review of a random subset of patients. A triangulated data approach was used to identify suspicion of lymphoma and milestones in the patient journey and to measure delays in diagnosis and treatment. Using an iterative consultative process, an algorithm was built to identify index events likely related to subsequent lymphoma diagnosis. Then, claims data was searched for a referring provider for each index event. The last visit with a referring provider, prior to the first index event, was selected as date of high suspicion. The study found that 14.8% of patients met the provincial target of less than sixty days from suspicion to treatment. Median time from high suspicion to treatment, referred to as system delay, was 128 days and the median time from diagnosis to treatment was 41 days. Time to diagnosis accounted for two thirds of system delay. In conclusion, this study demonstrated the merit of a triangulated approach. As well the clinical pathway developed and the target timelines for milestones have operational value and can be used to direct process improvements to shorten delays for future patients.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLymphomaen_US
dc.subjectdelayen_US
dc.subjectclinical pathwayen_US
dc.titleExamining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delayen_US
dc.typeinfo:eu-repo/semantics/masterThesis
dc.typemaster thesisen_US
dc.degree.disciplineCommunity Health Sciencesen_US
dc.contributor.examiningcommitteeDemers, Alain (Community Health Sciences) Seftel, Matthew (Internal Medicine)en_US
dc.degree.levelMaster of Science (M.Sc.)en_US
dc.description.noteFebruary 2017en_US
local.subject.manitobayesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record